Moreover, Liu et al. found that N6-methyladenosine-modified circIGF2BP3 impairs CD8 + T-cell responses and encourages tumor immune evasion by enhancing the deubiquitination of PD-L1 in NSCLC [15]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.